Presenting at CMSC 2022, researchers evaluated the prognostic value of baseline NfL for predicting clinical relapse and change in MRI lesion activity among patients with MS.
Researchers assessed the antiviral activity of several antiseptic agents against COVID-19 transmissibility.
Researchers sought to assess the incidence of Guillain-Barré syndrome following vaccination for Ad.26.COV2.S (Janssen) and mRNA vaccines.
Investigators examined the effect of obesity on microvascular and macrovascular complications among patients with type 1 or type 2 diabetes.
Researchers assessed the prevalence of gestational diabetes among women with COVID-19 infection who were pregnant and the risk factors associated with severe disease.
A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.
Researchers assessed the efficacy of an adjuvanted enterovirus 71 (EV71) vaccine for the prevention of EV71-associated infections among infants and children.
Researchers sought to evaluate whether there is any evidence from real-world data on treatment with tofacitinib, tocilizumab, or tumor necrosis factor and the risk for ADRD.
Researchers sought to identify the neuropathologic changes of COVID-19 in the olfactory region of patients who died with COVID-19 infection.
In a systematic review and meta-analysis, researchers compared and evaluated the effect differences of multiple acupuncture therapies for patients with primary insomnia.
